Together with azacitidine or decitabine, or very low-dose cytarabine in newly diagnosed AML aged ≥ 75 yrs or with co-morbidities that preclude the use of intensive induction chemotherapy Meanwhile, to be sure continued support, we have been displaying the site devoid of types and JavaScript. Mayo Clinic is really a https://directivepublications.org/journal-of-leukemia-research/